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ABSTRACT 
The overall aim of this thesis was to explore the association between the components of the metabolic 
syndrome (MetS), including vitamin D, and lower urinary tract symptoms (LUTS). The focus was on 
the relationship between diseases of the prostate, mainly benign prostatic enlargement (BPE) and 
prostate cancer (PC).  
The study cohort consisted of 3,014 Swedish men aged 69-81 enrolled in the Swedish arm of the 
Osteoporotic Fractures in men (MrOs) study. The study participants were randomly selected using 
population registries and then contacted and asked to participate in the study. The selected men were 
asked to fill in questionnaires regarding a variety of items such as daily activities and physical 
exercise, eating-, drinking- and smoking habits, medication, past and present history of diseases, 
voiding habits, surgery and current treatment. They underwent investigations regarding bone mineral 
density, measurements of body composition such as height, weight, body mass index, body fat mass 
and lean mass and blood samples were obtained for analyses of a variety of variables. In a subgroup of 
this cohort (1,010 individuals) more extended analyses were performed. Furthermore, in a small cohort 
(184 individuals), the prostate gland volumes were measured through transrectal ultrasonography. 
Lower urinary tract symptoms were measured by the International Prostate Symptom Score and 
urinary incontinence (UI) was evaluated by a questionnaire. The cohort has been followed for more 
than 10 years. The MrOs register was coordinated with the Swedish Death Register, the Swedish 
Cancer Register, and the National Prostate Cancer Register.  
This investigation showed that LUTS and UI were neither associated with any major component of the 
MetS, nor associated with serum levels of vitamin D. However, serum levels of serotonin were 
negatively associated with LUTS and UI, while fasting glucose and adiponectin were positively 
associated with LUTS. Benign prostatic enlargement was associated with low levels of vitamin D, 
serum calcium, sex hormone- binding globulin and high-density lipoprotein cholesterol. Individuals 
with type 2 Diabetes mellitus (T2DM) had a decreased risk of being diagnosed with incident prostate 
cancer. Increased levels of vitamin D were associated with increased risk of being diagnosed with PC. 
Individuals with low serum c-reactive-protein levels and taller individuals had a higher risk of 
developing PC. Plasma levels of osteocalcin, a protein produced by osteoblasts, were lower in 
individuals with T2DM, and higher in individuals with incident PC.  
The overall conclusions in the present thesis were that vitamin D was negatively associated with BPE 
and positively associated with PC, however, not associated with LUTS. In addition, the end-point 
component of MetS, T2DM, was positively associated with BPE but inversely associated with incident 
PC, and finally, that osteocalcin was positively associated with incident PC.  
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